An evolving challenge

Learning why tumours evolve is crucial, says Dr Marco Gerlinger, team leader in the ICR's centre for Evolution and Cancer

"Recently, immunotherapy has emerged as a powerful new tool that appears able to cure some cancers that are resistant to all other known therapies"

We are aiming to develop biomarkers that can measure and track diversity within tumours